Alain D. Baron
33Patents
11h-index
28Co-inventors
71Inventor score
Filing activity: Dec 17, 2003 → Jul 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8263545B2 | GIP analog and hybrid polypeptides with selectable properties | Human Necessities | 57 | Active |
| US8796338B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 22 | Active |
| US8497240B2 | DPP-IV resistant GIP hybrid polypeptides with selectable properties | Chemistry; Metallurgy | 21 | Active |
| US9211263B2 | Compositions and methods of treating metabolic disorders | Chemistry; Metallurgy | 20 | Active |
| US9050292B2 | Chemosensory receptor ligand-based therapies | Human Necessities | 18 | Active |
| US7790681B2 | Treatment of cardiac arrhythmias with GLP-1 receptor ligands | Human Necessities | 18 | Active |
| US8404637B2 | GIP analog and hybrid polypeptides with selectable properties | Chemistry; Metallurgy | 15 | Expired |
| US8389473B2 | Treatment of cardiac arrhythmias | Human Necessities | 15 | Active |
| US9463170B2 | Chemosensory receptor ligand-based therapies | Human Necessities | 12 | Active |
| US9481642B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 11 | Active |
| US9962344B2 | Chemosensory receptor ligand-based therapies | Human Necessities | 11 | Active |
| US10154972B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 8 | Active |
| US10201511B2 | Compositions and methods for treating metabolic disorders | Human Necessities | 7 | Active |
| US9480663B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 6 | Active |
| US9572784B2 | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | Chemistry; Metallurgy | 6 | Active |
| US10028923B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 6 | Active |
| US10159658B2 | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | Chemistry; Metallurgy | 6 | Active |
| US9770422B2 | Compositions and methods for treating metabolic disorders | Chemistry; Metallurgy | 6 | Active |
| US10610500B2 | Chemosensory receptor ligand-based therapies | Human Necessities | 6 | Active |
| US10668031B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 4 | Active |
| US10603291B2 | Compositions and methods for treating metabolic disorders | Chemistry; Metallurgy | 4 | Active |
| US8828953B2 | Chemosensory receptor ligand-based therapies | Human Necessities | 3 | Active |
| US8394765B2 | Methods of treating obesity with two different anti-obesity agents | Human Necessities | 3 | Active |
| US11065215B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 2 | Active |
| US9114560B2 | Blowing device comprising a nozzle and a supply duct forming an obtuse angle | Performing Operations; Transporting | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.